Core Insights - Health In Tech, Inc. is hosting hitDavos 2026, an independent global InsurTech and leadership summit during the World Economic Forum Week in Davos, Switzerland, focusing on leadership, innovation, and trust in complex global systems [1][2]. Event Overview - The summit will feature a full day of dialogue among heads of state, senior policymakers, industry CEOs, and cultural leaders, addressing topics such as geopolitical cooperation, AI adoption in regulated industries, and humanitarian resilience [2][3]. - The agenda includes moderated panels and fireside conversations aimed at fostering discussions on the intersection of technology, governance, and leadership amid rising global complexities [3][4]. Company Commitment - Health In Tech aims to reinforce its role as a convenor at the intersection of insurance, technology, and institutional reform, emphasizing trust, transparency, and scalable infrastructure in regulated markets [4][7]. - The company is committed to advancing ethical, compliant, and outcome-driven AI within healthcare and insurance, exemplified by initiatives like AskTim and HITChain [7]. Agenda Highlights - Key sessions will cover humanitarian resilience, blockchain and data rights in healthcare, and the geopolitical forces shaping innovation and economic progress [6][8]. - The program will conclude with a dialogue on peace, prosperity, and global cooperation, along with a special announcement from Abraham House [6]. Attendance and Access - Attendance is open to World Economic Forum participants and invited guests, with a detailed agenda and speaker lineup available on the event's official landing page [8][9].

Core Insights - Health In Tech and AlphaTON Capital are collaborating to develop HITChain, a blockchain-enabled insurance claims processing platform aimed at improving the efficiency and transparency of healthcare claims processing [3][4]. - The discussion at the Web Summit will focus on how blockchain technology can facilitate faster payments and enhance trust in healthcare data [2][5]. Company Overview - Health In Tech (Nasdaq: HIT) is an Insurtech platform that leverages third-party AI technology to streamline processes in the healthcare industry through vertical integration and automation [8]. - The company aims to address the inefficiencies in the healthcare claims process, which often involves outdated systems and delayed claims [4][8]. Event Details - The panel discussion titled "Blockchain Rx" will take place on November 12, 2025, at 11:35 AM on Stage 14 of the Web Summit in Lisbon, Portugal [6]. - Key speakers include Tim Johnson, Brittany Kaiser, and Dr. Dustin Plantholt, who will discuss the potential of blockchain in reshaping healthcare administration [2][6].

Company Overview - Health In Tech (HIT) is transforming healthcare through digital innovation, focusing on the self-funded healthcare insurance market for businesses [6, 7] - The company's AI-driven platform streamlines the design and purchase of healthcare plans, integrating brokers, employers, TPAs, carriers, hospitals, and clinics [7] - HITChain, a blockchain-enabled healthcare insurance claims processing platform, is being developed to target the $4.5 trillion U.S healthcare market and over $300 billion in annual claims administration costs [26, 27] Technology and Efficiency - HIT's integrated AI underwriting reduces underwriting time by 80%-90%, from 12 days/3 months to 2 minutes/2 weeks for small/large employers respectively [9, 10, 14, 15] - The eDIYBS platform empowers brokers to customize self-funded healthcare plans and generate bindable healthcare insurance quotes promptly [8, 13] - HI Performance National Network offers Medicare-based reimbursement pricing across 50 states, with 7,380 hospitals and 1,153,684 provider locations as of September 30, 2025 [16] Market and Financial Performance - Small businesses, employing 59 million people, contribute 44% ($12.7 trillion) of the GDP, representing a significant market opportunity [20, 21] - The U.S healthcare insurance market is a massive $1.7 trillion market primed for disruption [23, 25] - For the first nine months of 2025, revenue reached $25.8 million, a 132% increase compared to the full year 2024 revenue of $19.5 million [31] - Adjusted EBITDA for the first nine months of 2025 was $3.8 million, a 167% increase compared to the full year 2024 total of $2.3 million [31] - Cash and cash equivalents increased from $1.7 million in September 2024 to $8.0 million in September 2025 [44]

Core Insights - Health In Tech reported a strong financial performance for Q3 2025, with revenue reaching $8.5 million, a 90% increase year-over-year, and nine-month revenue totaling $25.8 million, which is 132% of the full-year 2024 revenue [3][5][22] - The company launched large-employer underwriting capabilities, significantly reducing the quote generation time for groups of 150 or more employees from three months to two weeks, enhancing its market position [3][10] - Health In Tech is addressing inefficiencies in U.S. healthcare claims administration, which costs the industry over $300 billion annually, through a strategic partnership with AlphaTON Capital to develop a blockchain-enabled claims infrastructure [3][10] Financial Performance - Revenue for Q3 2025 was $8.5 million, up 90% from $4.5 million in Q3 2024; nine-month revenue was $25.8 million, compared to $14.6 million in the same period last year, reflecting a 77% increase [5][22] - Adjusted EBITDA for Q3 2025 was $1.0 million, a 49% increase year-over-year, with nine-month adjusted EBITDA reaching $3.8 million, up 110% from the previous year [5][22] - Pre-tax income for Q3 2025 was $0.6 million, a 48% increase from $0.4 million in Q3 2024, with nine-month pre-tax income at $2.1 million, up 111.8% year-over-year [5][22] Business Developments - The number of billed enrolled employees increased to 25,248, representing a year-over-year increase of 7,654 employees [5] - The distribution network expanded to 849 partners, including brokers, TPAs, and agencies, marking a 57% increase year-over-year [5] - Health In Tech is set to host its first Independent InsurTech Summit during the World Economic Forum week in Davos, featuring panels on AI and women in leadership [10][23]

Core Insights - Health In Tech (Nasdaq: HIT) is expanding its agenda for the Independent InsurTech Summit during the World Economic Forum Week 2026 in Davos, Switzerland, highlighting its commitment to innovation and inclusivity in the insurance sector [1][3] Group 1: Event Details - The summit will feature a panel titled "First Ladies: Backing Women Who Build," focusing on women's entrepreneurship and leadership, with Cherie Blair as a featured speaker [2][4] - The event is scheduled for January 20, 2026, at 1:00 p.m. CET, and will be open to World Economic Forum participants and invited guests [5][4] Group 2: Company Initiatives - Health In Tech emphasizes its commitment to ethical AI through initiatives like AskTim, an AI benefits counselor, and HITChain, a framework for secure data validation [3][7] - The company aims to streamline processes in the healthcare industry by improving underwriting, sales, and service through vertical integration and automation [7]

Group 1 - Health In Tech Inc. (NASDAQ:HIT) is recognized as one of the best performing new tech stocks, having signed a non-binding strategic Letter of Intent with AlphaTON Capital Corp. (NASDAQ:ATON) on September 30 [1][2] - The collaboration aims to develop HITChain, a blockchain-enabled healthcare insurance claims processing platform utilizing The Open Network/TON, combining Health In Tech's insurance expertise with AlphaTON's blockchain infrastructure [2][3] - HITChain is designed to tackle inefficiencies, fraud, and lack of transparency in US healthcare claims processing, aiming to reduce administrative costs and enhance trust among stakeholders [3] Group 2 - Health In Tech operates as an insurance technology platform and offers a health intelligence card to streamline medical records and claims management [4] - AlphaTON Capital Corp. is a clinical-stage immune-oncology company focused on pharmaceutical and biotechnology product development [4]